Search for other papers by Monia Cito in
Google Scholar
PubMed
Search for other papers by Silvia Pellegrini in
Google Scholar
PubMed
Vita-Salute San Raffaele University, Milan, Italy
Search for other papers by Lorenzo Piemonti in
Google Scholar
PubMed
Search for other papers by Valeria Sordi in
Google Scholar
PubMed
Introduction Type 1 diabetes (T1D) is an autoimmune disorder characterized by insulin-producing β cell death caused by autoreactive T cells ( 1 ). T1D contributes to 10% of the total 422 million diabetes cases worldwide. Although T1D is no
Search for other papers by Ann-Kristin Picke in
Google Scholar
PubMed
Search for other papers by Graeme Campbell in
Google Scholar
PubMed
Division of Bone and Mineral Diseases, Washington University in St Louis, St Louis, Missouri, USA
Search for other papers by Nicola Napoli in
Google Scholar
PubMed
Search for other papers by Lorenz C Hofbauer in
Google Scholar
PubMed
Search for other papers by Martina Rauner in
Google Scholar
PubMed
Introduction The prevalence of diabetes mellitus is increasing worldwide with diabetes-related complications accounting for up to 60–70% of health-care costs related to diabetes ( 1 , 2 ). Besides the well-known renal and cardiovascular
Search for other papers by Clemens Kamrath in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany
Search for other papers by Alexander Eckert in
Google Scholar
PubMed
Search for other papers by Birgit Rami-Merhar in
Google Scholar
PubMed
Search for other papers by Sebastian Kummer in
Google Scholar
PubMed
Search for other papers by Martin Wabitsch in
Google Scholar
PubMed
Search for other papers by Katharina Laubner in
Google Scholar
PubMed
Search for other papers by Florian Kopp in
Google Scholar
PubMed
Search for other papers by Silvia Müther in
Google Scholar
PubMed
Search for other papers by Steffen Mühldorfer in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
Introduction Diabetes mellitus due to insulin resistance is among the most prevalent endocrine disorders. It is commonly associated with obesity and lifestyle factors but may also occur in a very rare and severe form in patients with defects
Search for other papers by Mohamed Asrih in
Google Scholar
PubMed
Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by Flore Sinturel in
Google Scholar
PubMed
Search for other papers by Richard Dubos in
Google Scholar
PubMed
Search for other papers by Idris Guessous in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by Zoltan Pataky in
Google Scholar
PubMed
Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by Charna Dibner in
Google Scholar
PubMed
Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Introduction Obesity is rapidly increasing worldwide despite it being a major health concern ( 1 ). Excess weight represents a hazardous condition leading to the development of type 2 diabetes (T2D) and its complications, mainly cardiovascular
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Search for other papers by Lisa Arnetz in
Google Scholar
PubMed
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Search for other papers by Neda Rajamand Ekberg in
Google Scholar
PubMed
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Search for other papers by Kerstin Brismar in
Google Scholar
PubMed
Departments of Endocrinology, Molecular Medicine and Surgery, Metabolism and Diabetes
Search for other papers by Michael Alvarsson in
Google Scholar
PubMed
Introduction Along with progressive β-cell failure and insulin resistance, patients with type 2 diabetes (T2D) display disturbed regulation of cortisol and insulin-like growth factor 1 (IGF1) secretion (1) . Especially regarding the hypothalamus
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by Marie Auzanneau in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by Alexander J Eckert in
Google Scholar
PubMed
Department of Internal Medicine IV, University Hospital Tübingen, Germany
Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany
Search for other papers by Andreas Fritsche in
Google Scholar
PubMed
Division of Endocrinology and Diabetology, Department of Internal Medicine 1, University Hospital Ulm, Ulm, Germany
Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany
Search for other papers by Martin Heni in
Google Scholar
PubMed
Institute of Health Services Research and Health Economics, Center for Health and Society, Faculty of Medicine, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Institute of Health Services Research and Health Economics, German Diabetes Center (DDZ), Leibniz Centre for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Search for other papers by Andrea Icks in
Google Scholar
PubMed
Department of Psychiatry and Psychotherapy II, University Hospital Ulm, Um, Germany
Search for other papers by Annabel S Mueller-Stierlin in
Google Scholar
PubMed
Search for other papers by Ana Dugic in
Google Scholar
PubMed
Search for other papers by Alexander Risse in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by Stefanie Lanzinger in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
Introduction The prevalence of diabetes is increasing worldwide ( 1 ). The number of people with diabetes in Germany, which has been recently estimated as 6.2 million (about 10%) ( 2 ), is expected to reach more than 10 million people by 2040
Search for other papers by Raymond J Rodgers in
Google Scholar
PubMed
Search for other papers by Jodie C Avery in
Google Scholar
PubMed
Search for other papers by Vivienne M Moore in
Google Scholar
PubMed
Search for other papers by Michael J Davies in
Google Scholar
PubMed
Search for other papers by Ricardo Azziz in
Google Scholar
PubMed
Search for other papers by Elisabet Stener-Victorin in
Google Scholar
PubMed
Search for other papers by Lisa J Moran in
Google Scholar
PubMed
Search for other papers by Sarah A Robertson in
Google Scholar
PubMed
Search for other papers by Nigel K Stepto in
Google Scholar
PubMed
FertilitySA, Adelaide, South Australia, Australia
Search for other papers by Robert J Norman in
Google Scholar
PubMed
Search for other papers by Helena J Teede in
Google Scholar
PubMed
associated risk of gestational diabetes (GDM), impaired glucose tolerance, type 2 diabetes (DM2), non-alcoholic fatty liver disease (NAFLD), dyslipidaemia and increased risk factors for both cerebrovascular and cardiovascular disease ( 6 , 7 , 8 , 9
Search for other papers by Hoda Gad in
Google Scholar
PubMed
Search for other papers by Einas Elgassim in
Google Scholar
PubMed
Department of Internal Medicine, Albany Medical Center Hospital, Albany, New York, USA
Search for other papers by Ibrahim Mohammed in
Google Scholar
PubMed
Search for other papers by Ahmad Yaser Alhaddad in
Google Scholar
PubMed
Search for other papers by Hussein Ahmed Hussein Zaky Aly in
Google Scholar
PubMed
Search for other papers by John-John Cabibihan in
Google Scholar
PubMed
Search for other papers by Abdulaziz Al-Ali in
Google Scholar
PubMed
Search for other papers by Kishor Kumar Sadasivuni in
Google Scholar
PubMed
Search for other papers by Aliyaa Haji in
Google Scholar
PubMed
Search for other papers by Neila Lamine in
Google Scholar
PubMed
Search for other papers by Adnan Khan in
Google Scholar
PubMed
Search for other papers by Ioannis N Petropoulos in
Google Scholar
PubMed
Search for other papers by Georgios Ponirakis in
Google Scholar
PubMed
Search for other papers by Alise Kalteniece in
Google Scholar
PubMed
Search for other papers by Maryam Ferdousi in
Google Scholar
PubMed
Search for other papers by Shazli Azmi in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Royal Liverpool and Broadgreen University NHS Hospital Trust, Liverpool, UK
Division of Endocrinology, Diabetes and Gastroenterology, University of Manchester, Manchester, UK
Search for other papers by Uazman Alam in
Google Scholar
PubMed
Search for other papers by Wajeeha Abuhelaiqa in
Google Scholar
PubMed
Search for other papers by Amin Jayyousi in
Google Scholar
PubMed
Search for other papers by Dabia AlMohanadi in
Google Scholar
PubMed
Search for other papers by Khaled Baagar in
Google Scholar
PubMed
Institute of Cardiovascular Medicine, University of Manchester, Manchester, UK
Search for other papers by Rayaz A Malik in
Google Scholar
PubMed
Introduction Diabetic peripheral neuropathy (DPN) affects ~50% of people with diabetes mellitus (T1DM) and (T2DM) ( 1 , 2 ). It has an insidious onset, which can lead to painful diabetic neuropathy, erectile dysfunction, foot ulceration and
Search for other papers by Xun Gong in
Google Scholar
PubMed
Search for other papers by Lili You in
Google Scholar
PubMed
Search for other papers by Feng Li in
Google Scholar
PubMed
Search for other papers by Qingyu Chen in
Google Scholar
PubMed
Search for other papers by Chaogang Chen in
Google Scholar
PubMed
Search for other papers by Xiaoyun Zhang in
Google Scholar
PubMed
Search for other papers by Xiuwei Zhang in
Google Scholar
PubMed
Search for other papers by Wenting Xuan in
Google Scholar
PubMed
Search for other papers by Kan Sun in
Google Scholar
PubMed
Search for other papers by Guojuan Lao in
Google Scholar
PubMed
Search for other papers by Chuan Wang in
Google Scholar
PubMed
Search for other papers by Yan Li in
Google Scholar
PubMed
Search for other papers by Mingtong Xu in
Google Scholar
PubMed
Search for other papers by Meng Ren in
Google Scholar
PubMed
Search for other papers by Li Yan in
Google Scholar
PubMed
Introduction Diabetes mellitus is a global public health issue that causes huge economic and medical burdens worldwide. The prevalence of diabetes has increased over the past few decades, especially in Asian population ( 1 ). A national cross
Search for other papers by Helga Schultz in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Svend Aage Engelholm in
Google Scholar
PubMed
Search for other papers by Eva Harder in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulrik Pedersen-Bjergaard in
Google Scholar
PubMed
Search for other papers by Peter Lommer Kristensen in
Google Scholar
PubMed
(MSCC) and brain tumours. Diabetes mellitus (DM) is a well-known metabolic side effect from treatment with glucocorticoids. The diabetogenic effect is mainly a result of insulin resistance in muscle and fatty tissue, increased production of glucose from